• OPEN AN ACCOUNT
Indian Indices
Sensex
80,999.40 -28.62
( -0.04%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
382.3238894
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
117.71
114348.68
EPS(TTM)
Face Value()
Div & Yield %
11.63
1
0.58
 

Vardhman Concrete reports standalone net loss of Rs 0.02 crore in the March 2026 quarter
May 26,2026
Net loss of Vardhman Concrete reported to Rs 0.02 crore in the quarter ended March 2026 as against net profit of Rs 0.75 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.12 crore in the year ended March 2026 as against net loss of Rs 0.47 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.